For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Depomed, Inc.

USPTO Granted Patents = 51

% Expired Patents = 70.6

CIPO Patents = 7

EPO Patents = 5

Trademarks = 11

Forward Citations = 2,171

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Bret Berner (29 out of 65 patents)

Sui Yuen Eddie Hou (24 out of 27 patents)

Gloria Gusler (17 out of 18 patents)

4. Jenny Louie-Helm (14 out of 14 patents)

5. John N Shell (9 out of 9 patents)

6. John W Shell (7 out of 25 patents)

7. Jong Lim (4 out of 4 patents)

8. Chien-Hsuan Han (4 out of 7 patents)

9. Monica L Reid (4 out of 4 patents)

10. Peter James Watts (3 out of 23 patents)

11. Jonathan David Castile (3 out of 9 patents)

12. Alan Smith (3 out of 21 patents)

13. Cuiping Chen (3 out of 5 patents)

14. Micheline Markey (3 out of 3 patents)

15. William Columbus Ian Lafferty (2 out of 3 patents)

Core Competencies:

Gastric Retentive

Oral Dosage Form

Pharmaceutical Compositions

Extended Release

CNS Disorders

Dual Drug Dosage

Zero-Order Release

Gabapentin

Non-Opioid Analgesics

Opioid Analgesics

Pain Management

GABA Analogs

51 patents: Sort by Forward Citations

1. 9980903 - Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract (2018-05-29),

2. 9937142 - Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders (2018-04-10),

3. 9814705 - Intranasal spray device containing pharmaceutical composition (2017-11-14),

4. 9801816 - Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract (2017-10-31),

5. 9597338 - Shell-and-core dosage form approaching zero-order drug release (2017-03-21),

6. 9572780 - Dual drug dosage forms with improved separation of drugs (2017-02-21),

7. 9566258 - Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders (2017-02-14),

8. 9561200 - Method of treating post-surgical acute pain (2017-02-07),

9. 9301934 - Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract (2016-04-05),

10. 9161911 - Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders (2015-10-20),

11. 9078814 - Intranasal spray device containing pharmaceutical composition (2015-07-14),

12. 9000046 - Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract (2015-04-07),

13. 8999388 - Dual drug dosage forms with improved separation of drugs (2015-04-07),

14. 8945619 - Shell-and-core dosage form approaching zero-order drug release (2015-02-03),

15. 8889176 - Method of managing or treating pain (2014-11-18),

Company Overview

Depomed, Inc., based in Menlo Park, California, specializes in the development and commercialization of innovative drug delivery technologies, particularly in the field of gastric retentive systems. The company focuses on creating oral dosage forms that provide extended release of pharmaceutical compositions, addressing various therapeutic areas including central nervous system disorders. Their core technologies encompass dual drug dosage forms and zero-order release mechanisms, enhancing the efficacy and patient compliance of medications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

51 Patents

#29 in Menlo Park, CA

#1,621 in California

#6,893 in US

#13,788 in the World

Menlo Park, CA, United States of America

Depomed, Inc.

Forward Citations = 2,171

27 inventors:

Bret Berner (29 out of 65 patents)

Sui Yuen Eddie Hou (24 out of 27 patents)

Gloria Gusler (17 out of 18 patents)

4. Jenny Louie-Helm (14 out of 14 patents)

5. John N Shell (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Depomed, Inc.. Retrieved from https://idiyas.com/company/depomed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…